Impacts of COVID-19 in Pathology and Cancer Care [Video]

Dr. Kaitlin Sundling, MD, PhD discusses the impact of COVID-19 on cancer patients and needed precautions the healthcare system needs to adopt to augment the safety of immunocompromised patients. A comprehensive listing of topics and discussions are listed in the timeline below. Health Watch USA(sm) meeting, April 14, 2024.

Timeline

02:00 Pap test a public health success story.
04:31 Decrease in cancer screening during the pandemic.
05:54 Recommended time for initial HPV primary screening.
07:46 Impact of COVID-19 on cancer screening.
09:18 Parallels between COVID-19 antivax movement and HPV vaccination adoption.
12:06 Other Viruses which can cause cancer (HPB, HBV, EBV, HIV, HHV-8, HTLV-1, Merkel cell Polyomavirus).
13:14 COVID-19’s lung damage pathology.
15:02 Pathology examples of COVID-19’s multi-system organ damage.
15:39 Long-term impact of COVID-19 on cancer risks is not known.
16:53 Many forms of Long COVID.
17:38 How can cancer patients decrease the chances of catching COVID-19?
19:27 Healthcare facilities and providers need to implement strategies to protect high-risk patients.
20:24 COVID-19 vaccination of cancer patients.
21:07 Cancer increases the risk of COVID-19.
22:15 Expert disagreement with the CDC’s relaxation of COVID-19 preventive strategies.
23:11 Misinformation similarities with COVID-19 and cancer.
24:21 Impact of COVID-19 on pathology practices and resident training, along with mitigation strategies.
26:51 Need for multi-layered COVID protections and virtual options in medical training and conferences.
28:06 Impact of artificial intelligence on pathological practices.
30:37 Dr. Rudolf Virchow: An old but new approach to medicine.
31:38 References and Resources

An expanded version of this talk (41 minutes) with a more detailed description of the PAP Test and HPV diagnoses along with an expanded comparison of automated versus human microscopic pathological diagnosis can be viewed at: https://youtu.be/76RIdKi34U8